Search results for "Coronavirus"


 
Results 91 - 100 of about 177 for "Coronavirus".
Sort by: Relevance | Newest | Oldest

Latest research on COVID-19 antibodies, cardiac and stroke risks, mortality rates

A monoclonal antibody treatment showed benefit in outpatients, data varied on duration of antibody response, cardiac effects appeared common while strokes were not, and mortality improved, among other recent findings on COVID-19.
https://immattersacp.org/weekly/archives/2020/11/03/1.htm
3 Nov 2020

New research on booster doses, breakthrough infections, long-term COVID-19 symptoms

A vaccine booster significantly reduced risk of severe disease or death from COVID-19, full vaccination provided more protection than previous infection, many patients reporting persistent symptoms did not have antibodies to SARS-CoV-2, and a trial of outpatient treatment was ineffective, recent studies found.
https://immattersacp.org/weekly/archives/2021/11/09/1.htm
9 Nov 2021

Anaphylaxis appears rare with COVID-19 vaccine, alternative administration strategies considered

The CDC's monitoring system found low rates of anaphylaxis after a first dose of the Pfizer-BioNTech COVID-19 vaccine, peer-reviewed data were published on the Moderna vaccine, and alternate vaccine administration strategies were evaluated.
https://immattersacp.org/weekly/archives/2021/01/12/2.htm
12 Jan 2021

Regulatory changes for COVID-19 vaccine; data on waning immunity, outpatient therapies

The FDA authorized vaccinating children, the NIH supported concurrent use of flu and COVID-19 shots, and the CDC addressed a fourth dose of COVID-19 vaccine for the immunocompromised. Trials found benefit from a new monoclonal antibody and an old antidepressant for high-risk outpatients.
https://immattersacp.org/weekly/archives/2021/11/02/1.htm
2 Nov 2021

More data on risk factors for poor COVID-19 outcomes, mixed results from treatment trials

A risk calculator, genetic findings, and red blood cell distribution width helped predict severity of and death from COVID-19. Tocilizumab showed benefit, but a number of other treatments, including CPR, did not, according to recent research.
https://immattersacp.org/weekly/archives/2020/09/29/2.htm
29 Sep 2020

New ACP resources on primary care reopening and recovery available

Resuming primary care is a key priority for supporting the U.S. health care system's capacity to manage and recover from the COVID-19 pandemic.
https://immattersacp.org/weekly/archives/2020/06/02/2.htm
2 Jun 2020

Progress and limitations on vaccines, strokes and readmissions in COVID-19

A report warned that a few health care workers developed COVID-19 shortly after vaccination, and studies showed that strokes were rare in COVID-19 patients but readmissions could not be predicted easily.
https://immattersacp.org/weekly/archives/2021/02/09/1.htm
9 Feb 2021

Q&A: Dealing with COVID-19 vaccine allocation, distribution

The new availability of vaccines has highlighted the challenges of allocation and distribution, which were the focus of a recent forum hosted by ACP and Annals of Internal Medicine.
https://immattersacp.org/weekly/archives/2021/02/02/2.htm
2 Feb 2021

New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports

The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2021/06/29/1.htm
29 Jun 2021

Research, news about COVID-19 vaccines, resources from ACP on flu vaccination

Results of vaccine trials were positive, but concerns arose about safety.
https://immattersacp.org/weekly/archives/2020/09/15/1.htm
15 Sep 2020

Result Page: Prev   5   6   7   8   9   10   11   12   13   14   Next